“A welcome addition to the literature”: Sabinsa publishes safety data for ForsLean
ForsLean, which has been a staple ingredient for Sabinsa for years, is an extract of the botanical Coleus forskohlii and is standardized to 10% or 20% forskohlin content. The new safety paper, published in the International Journal of Pharmacy and Pharmaceutical Research, concludes that there were no signs of toxicity in the repeated doses of 28 days (acute study) and 180 days (chronic study) with Coleus forskohlii (containing 10% forskohlin).
As such, the authors stated that repeated oral exposure to this extract up to 1000 mg per kg of body weight per day does not produce any toxic effects. Therefore the extract was considered to have ‘No Observed Adverse Effect Level’ (NOAEL) under the test conditions employed.
In addition, no mutagenic activity has been observed for the ingredient, wrote the authors, led by Sabinsa Corporation and Sami Labs founder Dr. Muhammed Majeed. In other word, no adverse effects on DNA of the organism were found.
Michael McGuffin, president of the American Herbal Products Association, welcomed the publication of the data. “Coleus forskohlii root is a well-established ingredient with a long history of safety. Even for such well known herbs though, additions to the scientific literature are always welcome and this article serves to increase our understanding of the appropriate use of this important herb and its extracts,” he said.
“While Sabinsa continues to innovate new efficacious ingredients, we are also committed to delivering the safest ingredients possible,” added Shaheen Majeed, Sabinsa’s Marketing Director.
“Our award-winning ForsLean brand is set apart from other suppliers of Coleus forskohlii with our safety publications, patents, and human clinical studies. Substitutions just don’t have those advantages.”
Source: International Journal of Pharmacy and Pharmaceutical Research
December 2015, Vol. 5, Issue 1, Pages 219-238
“Investigation of Acute, Sub-Acute, Chronic Oral Toxicity and Mutagenicity of Coleus forskohlii Briq. Hydroethanolic Extract, Standardized for 10% Forskolin in Experimental Animals”
Authors: M. Majeed, et al.
